Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (571)	10/1/2001 11:45:01 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 3557

jci.org J Clin Invest, October 2001, Volume 108, Number 7, 963-964 Copyright ©2001 by the American Society for Clinical Investigation -------------------------------------------------------------------------------- Commentary Progress in the search for neuronal mechanisms coupling type 2 diabetes to obesity Michael W. Schwartz Division of Metabolism, Endocrinology and Nutrition, University of Washington, Harborview Medical Center, 325 Ninth Avenue, Box 359757, Seattle, Washington 98104-2499, USA. Phone: (206) 341-5288; Fax: (206) 341-5293; E-mail: mschwart@u.washington.edu. Obesity, insulin resistance, and type 2 diabetes are a tightly linked and increasingly common triad of metabolic disorders. A well-supported and widely accepted explanation for their association is that obesity-induced insulin resistance in tissues such as muscle, liver, and fat increases the demand for insulin, and that type 2 diabetes ensues when this heightened demand cannot be met by defective pancreatic ß cells. Despite the undeniable importance of adipocytes in the regulation of insulin sensitivity (see refs. 1-3 for recent reviews and insights into this interaction), this understanding of the pathogenesis of type 2 diabetes may yet be incomplete. Growing evidence suggests that the CNS plays a key role in glucose homeostasis, via brain pathways that overlap with those controlling food intake and body weight. Advancing this notion a step further is the study by Obici et al., published in this issue of the JCI (4), implicating a specific hypothalamic neuronal pathway — the melanocortin pathway — in the control of insulin sensitivity in peripheral tissues. The recognition that neuronal melanocortin signaling also figures prominently in energy homeostasis, the process whereby energy intake is matched to energy expenditure over time, suggests an intimate coupling of neuronal mechanisms regulating body weight and glucose metabolism (Figure 1). Disorders affecting key neuronal pathways can therefore be included among potential mechanisms linking obesity to type 2 diabetes (5). <snip>